<DOC>
	<DOCNO>NCT00619073</DOCNO>
	<brief_summary>Clopidogrel medication use decrease ability platelet form blood clot . The theory propose , patient coronary artery disease stroke , increase platelet function discontinuation clopidogrel therapy associate increase clot risk . However , theory never rigorously test . The goal research determine whether discontinuation clopidogrel result increase platelet function .</brief_summary>
	<brief_title>PACT ( Platelet Activity After Clopidogrel Termination )</brief_title>
	<detailed_description>In study , address question : discontinuation clopidogrel result platelet hyperreactivity ? We perform double-blind , placebo-controlled , crossover study normal subject , platelet reactivity measure clopidogrel placebo , clopidogrel placebo , various time point discontinuation clopidogrel placebo . The dose clopidogrel standard , FDA-approved dose : 75 mg daily . All subject treat aspirin 81 mg daily throughout 57 day study assessment clopidogrel arm placebo arm , clinically relevant question : patient remain aspirin , discontinuation clopidogrel result platelet hyperreactivity ?</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>Must normal healthy subject Must 2170 year old Must able take aspirin clopidogrel . Must able blood drawn 16 time approximately 3 month . Subject currently take aspirin another antiplatelet drug clopidogrel . Subject must free medication 10 day enrol study . Subject currently take nonsteroidal antiinflammatory drug ibuprofen naproxen . Subject must free medication 3 day enrol study . Subject currently take medication depression medication low blood pressure lower blood sugar . Subject pregnant may become pregnant study breast feeding . Subject know allergy aspirin clopidogrel . Cigarette smoking use nicotine product . Subject history following : coronary artery disease ; stroke ; bleed disorder ; ongoing bleeding ; previous lifethreatening hemorrhage ; stomach ulcer ; gastrointestinal bleeding within past 1 month ; major surgery within past 1 month ; minor surgery within past 2 week ; platelet transfusion within past 7 day . Subject blood count , measure prestudy drug blood sample , normal range . Subject enrol another clinical trial investigational drug .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>blood platelet</keyword>
	<keyword>platelet aggregation inhibitor</keyword>
	<keyword>antiplatelet drug</keyword>
	<keyword>clopidogrel</keyword>
</DOC>